AU730069B2 - Antipathogenic peptides and compositions comprising them - Google Patents

Antipathogenic peptides and compositions comprising them Download PDF

Info

Publication number
AU730069B2
AU730069B2 AU17319/97A AU1731997A AU730069B2 AU 730069 B2 AU730069 B2 AU 730069B2 AU 17319/97 A AU17319/97 A AU 17319/97A AU 1731997 A AU1731997 A AU 1731997A AU 730069 B2 AU730069 B2 AU 730069B2
Authority
AU
Australia
Prior art keywords
leu
lys
ile
peptide
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU17319/97A
Other languages
English (en)
Other versions
AU1731997A (en
Inventor
Ziv Oren
Yechiel Shai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of AU1731997A publication Critical patent/AU1731997A/en
Application granted granted Critical
Publication of AU730069B2 publication Critical patent/AU730069B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU17319/97A 1996-02-22 1997-02-20 Antipathogenic peptides and compositions comprising them Ceased AU730069B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL117223 1996-02-22
IL11722396A IL117223A0 (en) 1996-02-22 1996-02-22 Antipathogenic polypeptides and compositions comprising them
PCT/IL1997/000066 WO1997031019A2 (en) 1996-02-22 1997-02-20 Antipathogenic peptides and compositions comprising them

Publications (2)

Publication Number Publication Date
AU1731997A AU1731997A (en) 1997-09-10
AU730069B2 true AU730069B2 (en) 2001-02-22

Family

ID=11068576

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17319/97A Ceased AU730069B2 (en) 1996-02-22 1997-02-20 Antipathogenic peptides and compositions comprising them

Country Status (13)

Country Link
US (1) US6172038B1 (https=)
EP (1) EP0904291A2 (https=)
JP (1) JP2000506128A (https=)
KR (2) KR19990087100A (https=)
CN (1) CN1216549A (https=)
AU (1) AU730069B2 (https=)
BR (1) BR9707691A (https=)
CA (1) CA2247025A1 (https=)
CZ (1) CZ264398A3 (https=)
EA (1) EA199800754A1 (https=)
IL (2) IL117223A0 (https=)
NZ (1) NZ331219A (https=)
WO (1) WO1997031019A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2281204A1 (en) * 1997-02-20 1998-08-27 Yeda Research And Development Co., Ltd. Antipathogenic synthetic peptides and compositions comprising them
US7067109B1 (en) 1998-07-13 2006-06-27 Board Of Regents, The University Of Texas System Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids
US6818213B1 (en) * 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
PT1783222E (pt) 1998-10-23 2012-07-26 Kirin Amgen Inc Péptidos diméricos de trombopoietina que simulam a ligação ao receptor mpl e têm actividade trombopoiética
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
IL139720A0 (en) * 2000-11-16 2002-02-10 Yeda Res & Dev Diastereomeric peptides and pharmaceutical compositions comprising them
AU2004246909B2 (en) * 2003-06-19 2010-08-19 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
WO2006010057A2 (en) 2004-07-08 2006-01-26 Amgen Inc. Therapeutic peptides
EA011879B1 (ru) 2004-09-24 2009-06-30 Эмджин Инк. МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ
JP4849642B2 (ja) * 2004-11-24 2012-01-11 ネオプロ ラブス， エルエルシー 状態を処置するための方法および組成物
WO2006128289A1 (en) * 2005-06-02 2006-12-07 University Of Manitoba Use of brevinin-2r in the treatment of cancer
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
WO2007074457A2 (en) * 2005-12-27 2007-07-05 Yeda Research And Development Co. Ltd. Histidine-containing diastereomeric peptides and uses thereof
JP2009526046A (ja) * 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2014038004A1 (ja) * 2012-09-05 2014-03-13 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
JP6093528B2 (ja) * 2012-09-19 2017-03-08 株式会社ミルボン スクリーニング方法
US11103547B2 (en) 2016-02-04 2021-08-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
GB2557654A (en) * 2016-12-14 2018-06-27 Uea Enterprises Ltd Method for nucleic acid depletion
CN113528600A (zh) * 2021-07-08 2021-10-22 石河子大学 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法
CN119607173A (zh) * 2025-01-07 2025-03-14 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) 小分子肽lklkll在制备降血糖产品中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258454A (en) * 1988-09-01 1993-11-02 Riso National Laboratory Peptide synthesis method and solid support for use in the method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIOCHEMISTRY VOL 32 (1993) PP3291-3297 *
FEBS LETTERS VOL 259 NO 1 1989 PP103-106 *
INT. J PEPTIDE AND PROTEIN RESEARCH V.40 NO5 1992 P429-436 *

Also Published As

Publication number Publication date
WO1997031019A2 (en) 1997-08-28
NZ331219A (en) 2000-04-28
KR19990087100A (ko) 1999-12-15
IL125734A0 (en) 1999-04-11
AU1731997A (en) 1997-09-10
IL125734A (en) 2005-08-31
BR9707691A (pt) 1999-07-27
WO1997031019A3 (en) 1997-10-23
CN1216549A (zh) 1999-05-12
JP2000506128A (ja) 2000-05-23
KR20000071187A (ko) 2000-11-25
CZ264398A3 (cs) 1999-01-13
CA2247025A1 (en) 1997-08-28
IL117223A0 (en) 1996-06-18
EA199800754A1 (ru) 1999-10-28
EP0904291A2 (en) 1999-03-31
US6172038B1 (en) 2001-01-09

Similar Documents

Publication Publication Date Title
US7001983B1 (en) Antipathogenic synthetic peptides and compositions comprising them
AU730069B2 (en) Antipathogenic peptides and compositions comprising them
Oren et al. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure− function study
Strahilevitz et al. Spectrum of antimicrobial activity and assembly of dermaseptin-b and its precursor form in phospholipid membranes
EP2391636B1 (de) Antibiotische peptide
Hong et al. Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes
De Zoysa et al. Antimicrobial peptides with potential for biofilm eradication: synthesis and structure activity relationship studies of battacin peptides
JP5335241B2 (ja) 抗微生物ヘキサペプチド
Oren et al. Cyclization of a cytolytic amphipathic α-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function
Shin et al. Effects of the hinge region of cecropin A (1–8)–magainin 2 (1–12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
Shai Pardaxin: channel formation by a shark repellant peptide from fish
Zhu et al. Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1
Ponnappan et al. Membrane-active peptides from marine organisms—antimicrobials, cell-penetrating peptides and peptide toxins: applications and prospects
André et al. Structure–activity relationship-based optimization of small temporin-SHf analogs with potent antibacterial activity
Zhu et al. Antimicrobial and cytolytic activities and plausible mode of bactericidal action of the cell penetrating peptide penetratin and its Lys‐linked two‐stranded peptide
Saido-Sakanaka et al. Synthesis and characterization of bactericidal oligopeptides designed on the basis of an insect anti-bacterial peptide
Laurencin et al. De novo cyclic pseudopeptides containing aza-β3-amino acids exhibiting antimicrobial activities
Andrä et al. Shortened amoebapore analogs with enhanced antibacterial and cytolytic activity
KR100438416B1 (ko) Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
Kuhn-Nentwig et al. Cupiennin 1d*: the cytolytic activity depends on the hydrophobic N-terminus and is modulated by the polar C-terminus
JPH0730120B2 (ja) 抗バクテリア・抗マラリア性ペプタイド
MXPA99007799A (en) Antipathogenic synthetic peptides and compositions comprising them
MXPA98006869A (en) Antipathogenic peptides and compositions that buy them
Shai Mechanism of membrane permeation and pore formation by antimicrobial peptides

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired